AIM ImmunoTech Inc. beat EPS estimates 67% of the time across 3 reported quarters (2 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.12 | $-0.43 | -258.3% | Miss |
| Q12026 FY2026 | $-1.08 | $-0.69 | +36.1% | Beat |
| Q42025 FY2025 | $-0.94 | $-0.44 | +53.2% | Beat |
Back to AIM overview · AIM holders · AIM KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.